Fulltext

A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes

Ataie-Jafari A 1 , Loke SC , Rahmat AB , Larijani B , Abbasi F , Leow MK Show all authors , Yassin Z

Affiliations 

  • 1 Endocrinology and Metabolism Research Center (EMRC), Tehran University of Medical Sciences, Teheran, Iran; Faculty of Medicine and Health Sciences (FMHS), Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia. Electronic address: [email protected]
Clin Nutr, 2013 Dec;32(6):911-7.
PMID: 23395257 DOI: 10.1016/j.clnu.2013.01.012

Abstract

This participant-blinded parallel-group randomized placebo-controlled study demonstrated that alfacalcidol (vitamin D analogue) preserves beta cell function in newly diagnosed type 1 diabetes (T1DM) in children.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications